Vor Biopharma INC DEF 14A proxy statements

Vor Biopharma Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026, with key proposals including director elections and equity plan amendments.

Vor Biopharma Inc. calls a special meeting to approve a reverse stock split, the issuance of over 1 billion shares from warrants, and an expanded equity incentive plan.

Vor Biopharma is holding its annual meeting on May 22, 2025, to vote on director elections, an increase in authorized common stock, and ratification of its accounting firm.

Vor Biopharma Inc. is holding its annual meeting on May 22, 2025, to elect directors, approve an increase in authorized shares, and ratify the selection of Ernst & Young LLP as the independent auditor.

Vor Biopharma is holding its 2025 Annual Meeting of Stockholders virtually on May 22, 2025, to vote on key proposals including increasing authorized common stock, electing directors, and ratifying the selection of Ernst & Young LLP as the independent auditor.

Vor Biopharma announces the appointment of Fouad Namouni, M.D., to its Board of Directors, increasing the board size to seven members.

Vor Biopharma Inc. is holding its annual meeting on May 23, 2024, and is soliciting stockholder votes on the election of directors, an amendment to the equity incentive plan, and the ratification of the company's independent auditor.

Vor Biopharma is holding its annual stockholder meeting on May 23, 2024, to elect directors, approve an amendment to its equity incentive plan, and ratify the selection of its independent auditor.